GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $221,000 | -40.4% | 3,250 | -69.7% | 0.00% | – |
Q1 2022 | $371,000 | -69.8% | 10,714 | -67.4% | 0.00% | -100.0% |
Q3 2021 | $1,228,000 | +14.2% | 32,897 | +7.2% | 0.00% | 0.0% |
Q2 2021 | $1,075,000 | +189.8% | 30,697 | +236.5% | 0.00% | 0.0% |
Q1 2021 | $371,000 | -85.3% | 9,123 | -84.3% | 0.00% | -66.7% |
Q4 2020 | $2,523,000 | +2152.7% | 58,260 | +2554.2% | 0.00% | – |
Q1 2020 | $112,000 | -87.8% | 2,195 | -87.4% | 0.00% | -100.0% |
Q2 2019 | $918,000 | +134.8% | 17,467 | +135.9% | 0.00% | +200.0% |
Q1 2019 | $391,000 | -26.6% | 7,405 | -43.1% | 0.00% | -50.0% |
Q4 2018 | $533,000 | +40.3% | 13,004 | +29.8% | 0.00% | +100.0% |
Q3 2018 | $380,000 | -42.2% | 10,018 | -26.5% | 0.00% | -96.6% |
Q1 2018 | $658,000 | +647.7% | 13,635 | +321.0% | 0.03% | +625.0% |
Q2 2017 | $88,000 | +49.2% | 3,239 | -21.6% | 0.00% | 0.0% |
Q4 2016 | $59,000 | -40.4% | 4,131 | -30.9% | 0.00% | -42.9% |
Q2 2016 | $99,000 | +73.7% | 5,974 | +63.9% | 0.01% | +40.0% |
Q1 2016 | $57,000 | – | 3,644 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |